No Data
No Data
No Data
No Data
No Data
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Presentation to highlight baseline characteristics of Spruce's CAHmelia program evaluating tildacerfont in adult congenital adrenal hyperplasia (CAH), as an illustration of outcomes of current pediatric CAH disease
BusinesswireApr 22 16:05 ET
Spruce Biosciences(SPRB.US) 10% Shareholder Sells US$350.95K in Common Stocks
$Spruce Biosciences(SPRB.US)$ 10% Shareholder Novo Holdings A/S sold 465.02K shares of Common Stocks on Mar 21, 2024 at an average price of $0.7547 for a total value of $350.95K.Source: Announcement W
moomoo NewsMar 25 22:28 ET
Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)
Yahoo FinanceMar 23 08:47 ET
Spruce Biosciences(SPRB.US) 10% Shareholder Sells US$1.36 Million in Common Stocks
$Spruce Biosciences(SPRB.US)$ 10% Shareholder Novo Holdings A/S sold 1.79 million shares of Common Stocks on Mar 18, 19, 20, 2024 at an average price of $0.757 for a total value of $1.36 million.Sourc
moomoo NewsMar 20 21:36 ET
Spruce Biosciences(SPRB.US) 10% Shareholder Sells US$1.7 Million in Common Stocks
$Spruce Biosciences(SPRB.US)$ 10% Shareholder Novo Holdings A/S sold 1.91 million shares of Common Stocks on Mar 14, 2024 at an average price of $0.8884 for a total value of $1.7 million.Source: Annou
moomoo NewsMar 18 21:54 ET
Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Spruce Biosciences (SPRB)
TipRanksMar 18 00:30 ET
Julien198142 : why
hard-working Camel_4OP Julien198142: pre market show
The Real WojakOP : No walking away empty handed :\
No Data
No Data